Athira Pharma obtains preliminary approval for derivative lawsuit settlement with governance reforms

LeonaBio, Inc.

Court preliminary approval on May 3, 2024; final hearing set for July 18, 2024.
Settlement requires Athira to adopt corporate governance reforms and pay lead plaintiffs' attorney's fees, expenses, and service awards.
Derivative actions Bushansky v. Kawas and Houlihan v. Kawas covered by the Stipulation of Settlement dated March 15, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.